Multigene panel testing increases the number of loci associated with gastric cancer predisposition

Detalhes bibliográficos
Autor(a) principal: Tedaldi, G
Data de Publicação: 2019
Outros Autores: Pirini, F, Tebaldi, M, Zampiga, V, Cangini, I, Danesi, R, Arcangeli, V, Ravegnani, M, Khouzam, RA, Molinari, C, Oliveira, C, Morgagni, P, Saragoni, L, Bencivenga, M, Ulivi, P, Amadori, D, Martinelli, G, Falcini, F, Ranzani, GN, Calistri, D
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://hdl.handle.net/10216/137933
Resumo: The main gene involved in gastric cancer (GC) predisposition is CDH1, the pathogenic variants of which are associated with diffuse-type gastric cancer (DGC) and lobular breast cancer (LBC). CDH1 only explains a fraction (10–50%) of patients suspected of DGC/LBC genetic predisposition. To identify novel susceptibility genes, thus improving the management of families at risk, we performed a multigene panel testing on selected patients. We searched for germline pathogenic variants in 94 cancer-related genes in 96 GC or LBC Italian patients with early-onset and/or family history of GC. We found CDH1 pathogenic variants in 10.4% of patients. In 11.5% of cases, we identified loss-of-function variants in BRCA1, BRCA2, PALB2, and ATM breast/ovarian cancer susceptibility genes, as well as in MSH2, PMS2, BMPR1A, PRF1, and BLM genes. In 78.1% of patients, we did not find any variants with clear-cut clinical significance; however, 37.3% of these cases harbored rare missense variants predicted to be damaging by bioinformatics tools. Multigene panel testing decreased the number of patients that would have otherwise remained genetically unexplained. Besides CDH1, our results demonstrated that GC pathogenic variants are distributed across a number of susceptibility genes and reinforced the emerging link between gastric and breast cancer predisposition.
id RCAP_b01f48c6052020c8604f68807db9d42b
oai_identifier_str oai:repositorio-aberto.up.pt:10216/137933
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Multigene panel testing increases the number of loci associated with gastric cancer predispositionCancer predispositionCDH1 geneNext-generation sequencingStomach neoplasmsThe main gene involved in gastric cancer (GC) predisposition is CDH1, the pathogenic variants of which are associated with diffuse-type gastric cancer (DGC) and lobular breast cancer (LBC). CDH1 only explains a fraction (10–50%) of patients suspected of DGC/LBC genetic predisposition. To identify novel susceptibility genes, thus improving the management of families at risk, we performed a multigene panel testing on selected patients. We searched for germline pathogenic variants in 94 cancer-related genes in 96 GC or LBC Italian patients with early-onset and/or family history of GC. We found CDH1 pathogenic variants in 10.4% of patients. In 11.5% of cases, we identified loss-of-function variants in BRCA1, BRCA2, PALB2, and ATM breast/ovarian cancer susceptibility genes, as well as in MSH2, PMS2, BMPR1A, PRF1, and BLM genes. In 78.1% of patients, we did not find any variants with clear-cut clinical significance; however, 37.3% of these cases harbored rare missense variants predicted to be damaging by bioinformatics tools. Multigene panel testing decreased the number of patients that would have otherwise remained genetically unexplained. Besides CDH1, our results demonstrated that GC pathogenic variants are distributed across a number of susceptibility genes and reinforced the emerging link between gastric and breast cancer predisposition.MDPI20192019-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/10216/137933eng2072-669410.3390/cancers11091340Tedaldi, GPirini, FTebaldi, MZampiga, VCangini, IDanesi, RArcangeli, VRavegnani, MKhouzam, RAMolinari, COliveira, CMorgagni, PSaragoni, LBencivenga, MUlivi, PAmadori, DMartinelli, GFalcini, FRanzani, GNCalistri, Dinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-29T14:54:14Zoai:repositorio-aberto.up.pt:10216/137933Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T00:11:15.882753Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Multigene panel testing increases the number of loci associated with gastric cancer predisposition
title Multigene panel testing increases the number of loci associated with gastric cancer predisposition
spellingShingle Multigene panel testing increases the number of loci associated with gastric cancer predisposition
Tedaldi, G
Cancer predisposition
CDH1 gene
Next-generation sequencing
Stomach neoplasms
title_short Multigene panel testing increases the number of loci associated with gastric cancer predisposition
title_full Multigene panel testing increases the number of loci associated with gastric cancer predisposition
title_fullStr Multigene panel testing increases the number of loci associated with gastric cancer predisposition
title_full_unstemmed Multigene panel testing increases the number of loci associated with gastric cancer predisposition
title_sort Multigene panel testing increases the number of loci associated with gastric cancer predisposition
author Tedaldi, G
author_facet Tedaldi, G
Pirini, F
Tebaldi, M
Zampiga, V
Cangini, I
Danesi, R
Arcangeli, V
Ravegnani, M
Khouzam, RA
Molinari, C
Oliveira, C
Morgagni, P
Saragoni, L
Bencivenga, M
Ulivi, P
Amadori, D
Martinelli, G
Falcini, F
Ranzani, GN
Calistri, D
author_role author
author2 Pirini, F
Tebaldi, M
Zampiga, V
Cangini, I
Danesi, R
Arcangeli, V
Ravegnani, M
Khouzam, RA
Molinari, C
Oliveira, C
Morgagni, P
Saragoni, L
Bencivenga, M
Ulivi, P
Amadori, D
Martinelli, G
Falcini, F
Ranzani, GN
Calistri, D
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Tedaldi, G
Pirini, F
Tebaldi, M
Zampiga, V
Cangini, I
Danesi, R
Arcangeli, V
Ravegnani, M
Khouzam, RA
Molinari, C
Oliveira, C
Morgagni, P
Saragoni, L
Bencivenga, M
Ulivi, P
Amadori, D
Martinelli, G
Falcini, F
Ranzani, GN
Calistri, D
dc.subject.por.fl_str_mv Cancer predisposition
CDH1 gene
Next-generation sequencing
Stomach neoplasms
topic Cancer predisposition
CDH1 gene
Next-generation sequencing
Stomach neoplasms
description The main gene involved in gastric cancer (GC) predisposition is CDH1, the pathogenic variants of which are associated with diffuse-type gastric cancer (DGC) and lobular breast cancer (LBC). CDH1 only explains a fraction (10–50%) of patients suspected of DGC/LBC genetic predisposition. To identify novel susceptibility genes, thus improving the management of families at risk, we performed a multigene panel testing on selected patients. We searched for germline pathogenic variants in 94 cancer-related genes in 96 GC or LBC Italian patients with early-onset and/or family history of GC. We found CDH1 pathogenic variants in 10.4% of patients. In 11.5% of cases, we identified loss-of-function variants in BRCA1, BRCA2, PALB2, and ATM breast/ovarian cancer susceptibility genes, as well as in MSH2, PMS2, BMPR1A, PRF1, and BLM genes. In 78.1% of patients, we did not find any variants with clear-cut clinical significance; however, 37.3% of these cases harbored rare missense variants predicted to be damaging by bioinformatics tools. Multigene panel testing decreased the number of patients that would have otherwise remained genetically unexplained. Besides CDH1, our results demonstrated that GC pathogenic variants are distributed across a number of susceptibility genes and reinforced the emerging link between gastric and breast cancer predisposition.
publishDate 2019
dc.date.none.fl_str_mv 2019
2019-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://hdl.handle.net/10216/137933
url https://hdl.handle.net/10216/137933
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 2072-6694
10.3390/cancers11091340
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799136035929587712